Variant report

Variant	nsv974585
Chromosome Location	chr15:59693187-59700169
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:41)
CpG islands
(count:61)
Chromatin interactive
region (count:0)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:41 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr15:59698512-59699056	GM12878	blood:	n/a	n/a
2	BCLAF1	chr15:59698552-59699103	GM12878	blood:	n/a	n/a
3	CEBPB	chr15:59698693-59698860	A549	lung:	n/a	chr15:59698773-59698784
4	CEBPB	chr15:59698674-59698874	HepG2	liver:	n/a	chr15:59698773-59698784
5	CEBPB	chr15:59698648-59698871	K562	blood:	n/a	chr15:59698773-59698784
6	CTCF	chr15:59698250-59698523	GM12878	blood:	n/a	n/a
7	CTCF	chr15:59699880-59700030	GM12865	blood:	n/a	n/a
8	CTCF	chr15:59700100-59700250	GM12865	blood:	n/a	n/a
9	CTCF	chr15:59700060-59700210	GM12868	blood:	n/a	n/a
10	CTCF	chr15:59700120-59700270	GM12867	blood:	n/a	n/a
11	EBF1	chr15:59698696-59699000	GM12878	blood:	n/a	n/a
12	EP300	chr15:59698710-59698963	GM12878	blood:	n/a	n/a
13	EP300	chr15:59698796-59699018	GM12878	blood:	n/a	n/a
14	FOXA1	chr15:59693879-59694449	HepG2	liver:	n/a	n/a
15	FOXA1	chr15:59694004-59694449	HepG2	liver:	n/a	n/a
16	FOXA1	chr15:59694065-59694272	T-47D	breast:	n/a	n/a
17	FOXA1	chr15:59694025-59694351	HepG2	liver:	n/a	n/a
18	FOXA1	chr15:59693922-59694312	HepG2	liver:	n/a	n/a
19	FOXA1	chr15:59694017-59694287	T-47D	breast:	n/a	n/a
20	FOXA2	chr15:59694018-59694327	A549	lung:	n/a	n/a
21	FOXA2	chr15:59694066-59694322	HepG2	liver:	n/a	n/a
22	FOXM1	chr15:59698597-59699119	GM12878	blood:	n/a	n/a
23	MEF2A	chr15:59698508-59699124	GM12878	blood:	n/a	n/a
24	MEF2A	chr15:59698494-59699153	GM12878	blood:	n/a	n/a
25	MEF2C	chr15:59698500-59699125	GM12878	blood:	n/a	n/a
26	MTA3	chr15:59698229-59699207	GM12878	blood:	n/a	n/a
27	MXI1	chr15:59698684-59698884	GM12878	blood:	n/a	n/a
28	NFATC1	chr15:59698557-59699041	GM12878	blood:	n/a	n/a
29	NFIC	chr15:59698409-59699212	GM12878	blood:	n/a	n/a
30	NFIC	chr15:59698526-59699054	GM12878	blood:	n/a	n/a
31	POLR2A	chr15:59698467-59698578	GM12878	blood:	n/a	n/a
32	RCOR1	chr15:59695630-59695631	Hela-S3	cervix:	n/a	n/a
33	RUNX3	chr15:59698553-59699056	GM12878	blood:	n/a	n/a
34	RUNX3	chr15:59698320-59699139	GM12878	blood:	n/a	n/a
35	SMC3	chr15:59698408-59698518	GM12878	blood:	n/a	n/a
36	SPI1	chr15:59698687-59698979	GM12891	blood:	n/a	n/a
37	SPI1	chr15:59693738-59693952	GM12878	blood:	n/a	n/a
38	SPI1	chr15:59693633-59693996	GM12891	blood:	n/a	n/a
39	TBL1XR1	chr15:59698585-59699051	GM12878	blood:	n/a	n/a
40	YY1	chr15:59699172-59699435	GM12878	blood:	n/a	n/a
41	ZNF384	chr15:59699045-59699268	GM12878	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr15:59694115-59694165	NT2-D1	testis:	n/a
2	chr15:59694115-59694165	SKMC	muscle:	n/a
3	chr15:59694115-59694165	AG04450	lung:	fetal
4	chr15:59694115-59694165	HEEpiC	esophagus:	n/a
5	chr15:59694115-59694165	HRPEpiC	eye:	n/a
6	chr15:59694115-59694165	ProgFib	skin:	n/a
7	chr15:59694115-59694165	HRCEpiC	kidney:	n/a
8	chr15:59694115-59694165	PFSK-1	brain:	n/a
9	chr15:59694115-59694165	RPTEC	kidney:	n/a
10	chr15:59694115-59694165	HL-60	blood:	n/a
11	chr15:59694115-59694165	AG04449	skin:	fetal
12	chr15:59694115-59694165	NB4	blood:	n/a
13	chr15:59694115-59694165	BJ	skin:	n/a
14	chr15:59694115-59694165	NHBE	bronchial:	n/a
15	chr15:59694115-59694165	SK-N-SH	brain:	n/a
16	chr15:59694115-59694165	AG09309	skin:	n/a
17	chr15:59694115-59694165	SK-N-SH_RA	brain:	n/a
18	chr15:59694115-59694165	NH-A	brain:	n/a
19	chr15:59694115-59694165	GM06990	blood:	n/a
20	chr15:59694115-59694165	NHDF-neo	bronchial:	n/a
21	chr15:59694115-59694165	IMR90	lung:	fetal
22	chr15:59694115-59694165	LNCaP	prostate:	n/a
23	chr15:59694115-59694165	HAEpiC	amniotic membrane:	n/a
24	chr15:59694115-59694165	ovcar-3	ovarian:	n/a
25	chr15:59694115-59694165	HCT-116	colon:	n/a
26	chr15:59694115-59694165	GM12891	blood:	n/a
27	chr15:59694115-59694165	PrEC	prostate:	n/a
28	chr15:59694115-59694165	SK-N-MC	brain:	n/a
29	chr15:59694115-59694165	K562	blood:	n/a
30	chr15:59694115-59694165	HMEC	breast:	n/a
31	chr15:59694115-59694165	HepG2	liver:	n/a
32	chr15:59694115-59694165	H1-hESC	embryonic stem cell:	embryo
33	chr15:59694115-59694165	HCF	heart:	n/a
34	chr15:59694115-59694165	HEK293	kidney:	embryo
35	chr15:59694115-59694165	SAEC	small airway:	n/a
36	chr15:59694115-59694165	HRE	kidney:	n/a
37	chr15:59694115-59694165	T-47D	breast:	n/a
38	chr15:59694115-59694165	U87	brain:	n/a
39	chr15:59694115-59694165	GM12892	blood:	n/a
40	chr15:59694115-59694165	BE2_C	brain:	n/a
41	chr15:59694115-59694165	MCF10A-Er-Src	breast:	n/a
42	chr15:59694115-59694165	HNPCEpiC	eye:	n/a
43	chr15:59694115-59694165	GM12878	blood:	n/a
44	chr15:59694115-59694165	HIPEpiC	eye:	n/a
45	chr15:59694115-59694165	AG10803	skin:	n/a
46	chr15:59694115-59694165	AG09319	gingival:	n/a
47	chr15:59694115-59694165	PANC-1	pancreas:	n/a
48	chr15:59694115-59694165	HUVEC	blood vessel:	n/a
49	chr15:59694115-59694165	A549	lung:	n/a
50	chr15:59694115-59694165	HCPEpiC	choroid plexus:	n/a

No data

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LDHAL6B-3	chr15:59694475-59694557	NONHSAT044165

No data

Variant related genes	Relation type
ENSG00000259750	TF binding region
ENSG00000200252	TF binding region
ENSG00000259750	CpG island
ENSG00000200252	CpG island

Extended variants
information (count: 337 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:337 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185634459	chr15:59693203-59693204	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs557041477	chr15:59693211-59693212	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs566885675	chr15:59693233-59693234	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs552140182	chr15:59693237-59693238	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs375526761	chr15:59693271-59693272	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs372250126	chr15:59693279-59693280	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs550515879	chr15:59693281-59693282	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs146745820	chr15:59693380-59693381	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs77916779	chr15:59693387-59693388	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs369425440	chr15:59693393-59693394	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs561573641	chr15:59693408-59693409	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs528650799	chr15:59693421-59693422	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs540558571	chr15:59693437-59693438	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs565215721	chr15:59693438-59693439	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs148905637	chr15:59693466-59693467	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs190504639	chr15:59693473-59693474	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs569503528	chr15:59693490-59693491	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs115258193	chr15:59693564-59693565	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs548796145	chr15:59693591-59693592	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs567505027	chr15:59693592-59693593	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs534790925	chr15:59693617-59693618	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs553179246	chr15:59693670-59693671	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs571582708	chr15:59693672-59693673	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs549656607	chr15:59693719-59693720	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs538513844	chr15:59693729-59693730	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs557325062	chr15:59693756-59693757	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs567064848	chr15:59693766-59693767	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs193277984	chr15:59693790-59693791	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs142592824	chr15:59693841-59693842	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs554749262	chr15:59693850-59693851	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs573127446	chr15:59693913-59693914	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs201316272	chr15:59693919-59693920	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs540448156	chr15:59693928-59693929	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs565101278	chr15:59693964-59693965	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs60893786	chr15:59693969-59693970	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs572624478	chr15:59693970-59693971	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs541617445	chr15:59693971-59693972	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs578081120	chr15:59693972-59693973	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs57470869	chr15:59693983-59693984	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs397692100	chr15:59693984-59693985	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs374028157	chr15:59693985-59693986	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs58617007	chr15:59694003-59694004	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs150983818	chr15:59694078-59694079	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs555325690	chr15:59694100-59694101	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs183673038	chr15:59694116-59694117	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs377702193	chr15:59694132-59694133	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs530411185	chr15:59694143-59694144	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs116360542	chr15:59694208-59694209	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs140852673	chr15:59694238-59694239	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs112557881	chr15:59694257-59694258	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Schizophrenia	19415332	CNVD
Breast cancer	22522925	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Testicular germ cell tumor	18059402	CNVD
cataract	16735990	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Medulloblastoma	21979893	CNVD
spastic paraplegia with thinning of corpus callosum	19105190	CNVD
Schizophrenia	21324950	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Disease	21824424	CNVD
Melanoma	18172304	CNVD
Gastric cancer	17167181	CNVD
Neuroblastoma	19435921	CNVD
Colorectal cancer	19359472	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Colorectal cancer	16272173	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Multiple myeloma	17550852	CNVD
Intellectual disability	22102821	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	20724749	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Prostate cancer	18632612	CNVD
small cell lung cancer	20016488	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Cancer	21129771	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Abnormal phenotypes	18644119	CNVD
Cancer	16751803	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Holoprosencephaly	21359414	CNVD
Myelofibrosis	22110671	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Mental retardation	17124404	CNVD
Gastrointestinal stromal cancer	20877625	CNVD

Chromatin state (count:147 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr15:59675200-59703000	Weak transcription	Aorta	Aorta
2	chr15:59678000-59693400	Weak transcription	Liver	Liver
3	chr15:59681400-59694200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr15:59688400-59698800	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr15:59689200-59693800	Weak transcription	A549	lung
6	chr15:59690400-59694200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
7	chr15:59690800-59695600	Weak transcription	Lung	lung
8	chr15:59690800-59702600	Weak transcription	Left Ventricle	heart
9	chr15:59691400-59693200	Flanking Active TSS	GM12878-XiMat	blood
10	chr15:59691400-59693600	Enhancers	Brain Substantia Nigra	brain
11	chr15:59691400-59693800	Enhancers	Brain Hippocampus Middle	brain
12	chr15:59691800-59693600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
13	chr15:59691800-59693600	Enhancers	Placenta	Placenta
14	chr15:59691800-59694600	Enhancers	Rectal Mucosa Donor 29	rectum
15	chr15:59692000-59694800	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
16	chr15:59692200-59693600	Enhancers	Brain Anterior Caudate	brain
17	chr15:59692400-59693400	Weak transcription	Rectal Mucosa Donor 31	rectum
18	chr15:59692400-59693800	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
19	chr15:59692600-59693200	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
20	chr15:59692600-59694000	Weak transcription	Stomach Mucosa	stomach
21	chr15:59692600-59694800	Enhancers	Sigmoid Colon	Sigmoid Colon
22	chr15:59692600-59698000	Weak transcription	Primary hematopoietic stem cells short term culture	blood
23	chr15:59692600-59701400	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr15:59692800-59693200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
25	chr15:59692800-59693200	Enhancers	Brain Cingulate Gyrus	brain
26	chr15:59692800-59694200	Weak transcription	Small Intestine	intestine
27	chr15:59692800-59694600	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr15:59692800-59694800	Enhancers	HUES6 Cell Line	embryonic stem cell
29	chr15:59692800-59694800	Enhancers	Primary B cells from peripheral blood	blood
30	chr15:59692800-59694800	Enhancers	Cortex derived primary cultured neurospheres	brain
31	chr15:59692800-59694800	Enhancers	Brain Germinal Matrix	brain
32	chr15:59692800-59695600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
33	chr15:59692800-59698200	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
34	chr15:59692800-59704800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr15:59693000-59693200	Enhancers	Brain Inferior Temporal Lobe	brain
36	chr15:59693000-59693400	Weak transcription	Pancreas	Pancrea
37	chr15:59693000-59694000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr15:59693000-59694000	Weak transcription	Adipose Nuclei	Adipose
39	chr15:59693000-59694200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
40	chr15:59693000-59694400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
41	chr15:59693000-59694800	Enhancers	Primary B cells from cord blood	blood
42	chr15:59693000-59695800	Enhancers	H1 Cell Line	embryonic stem cell
43	chr15:59693000-59704800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
44	chr15:59693000-59704800	Weak transcription	Spleen	Spleen
45	chr15:59693000-59705000	Weak transcription	Fetal Thymus	thymus
46	chr15:59693200-59693600	Enhancers	GM12878-XiMat	blood
47	chr15:59693200-59693800	Enhancers	iPS-18 Cell Line	embryonic stem cell
48	chr15:59693400-59693600	Enhancers	Colonic Mucosa	Colon
49	chr15:59693400-59693600	Enhancers	Pancreas	Pancrea
50	chr15:59693400-59694400	Enhancers	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links